Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Ionis Pharmaceuticals Inc
IONS
Healthcare
Biotechnology
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for...
pediatric and adult patients with spinal muscular atrophy (SMA). It also provides QALSODY for the treatment of Amyotrophic Lateral Sclerosis (ALS); TEGSEDI for the treatment of ATTRv-PN in adults; and WAYLIVRA for treatment for FCS and familial partial lipodystrophy. It also develops products under Phase 3 clinical trials, such as Olezarsen for patients with hypertriglyceridemia (SHTG) and cardiovascular disease (CVD); Donidalorsen for patients with hereditary angioedema; and Zilganerse, a potential treatment for people with genetically confirmed Alexander disease, as well as ION582 that has c...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:IONS)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
mart33
X
Post by
mart33
on Apr 10, 2008 8:23pm
VP exercised options
A vice president of Isis Pharmaceuticals Inc. exercised options for 12,200 shares of common stock and sold them under a prearranged trading plan, according to a Securities and Exchange Commission
...more
(0)
•••
mart33
X
Post by
mart33
on Mar 24, 2008 8:34pm
news and potential uptrend
Isis Pharmaceuticals last week reported a sharp drop in its net loss for 2007 despite higher operating expenses as the company experienced a strong increase in collaboration-related revenues
...more
Secure your spot for the exclusive 2026 ROTH Energy Day Fireside Chats in Houston
posted Feb 07, 2026 9:00am by
Stockhouse Publishing Ltd.
-
|
Join us for ROTH Energy Day, a series of interactive fireside chats with senior executives of select public energy issuers. Thu. Feb. 19, 2026 in Houston TX ...REGISTER NOW
(0)
•••
bearsko
X
Post by
bearsko
on Feb 25, 2008 3:07pm
Overview of the stock
Here are some points to consider:1) Biotech industry is very volatile though ISIS stock prices started accelerating upwards in August and have been smoothly trending up until December.2) Positive
...more
(0)
•••
kungfu010
X
Post by
kungfu010
on Apr 27, 2007 3:09pm
isis needs a kiss of life
Maybe Tobin is the volunteer...trading on the 27th April,07 @ $10.22
(0)
•••
Silver_Is_Money
X
Post by
Silver_Is_Money
on Feb 04, 2007 6:48am
Tobin Smith is pumping ISIS presently
Wow, I can't believe that no one has left a message on this board since 2003. Toby Smith (Tobin) is calling this one a major buy-out candidate. Says it won't be around any more within about
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Eshbal Functional Food (V.ESBL) Acquires Gluten Free Nation
Drilling Intersects 103.35M Grading 0.88 g/t Gold with a Higher-Grade Subset of 56.40M of 1.35 g/t
Be part of the 2026 ROTH Energy Day in Houston - register now to attend the energy fireside chats
Podcasts